163 related articles for article (PubMed ID: 6226225)
21. Functional significance of anti-T-lymphocyte antibodies in sarcoidosis.
Spurzem JR; Saltini C; Crystal RG
Am Rev Respir Dis; 1988 Mar; 137(3):600-5. PubMed ID: 2964216
[TBL] [Abstract][Full Text] [Related]
22. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
Robinson BW; McLemore TL; Crystal RG
J Clin Invest; 1985 May; 75(5):1488-95. PubMed ID: 3923038
[TBL] [Abstract][Full Text] [Related]
23. Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors.
Hancock WW; Kobzik L; Colby AJ; O'Hara CJ; Cooper AG; Godleski JJ
Am J Pathol; 1986 Apr; 123(1):1-8. PubMed ID: 3083688
[TBL] [Abstract][Full Text] [Related]
24. T-lymphocyte subsets and immunoglobulin concentrations in bronchoalveolar lavage of patients with sarcoidosis and high and low intensity alveolitis.
Bauer W; Gorny MK; Baumann HR; Morell A
Am Rev Respir Dis; 1985 Nov; 132(5):1060-5. PubMed ID: 3877480
[TBL] [Abstract][Full Text] [Related]
25. Corticosteroid therapy suppresses spontaneous interleukin 2 release and spontaneous proliferation of lung T lymphocytes of patients with active pulmonary sarcoidosis.
Pinkston P; Saltini C; Müller-Quernheim J; Crystal RG
J Immunol; 1987 Aug; 139(3):755-60. PubMed ID: 3496388
[TBL] [Abstract][Full Text] [Related]
26. Spontaneous release of interleukin 2 by lung T lymphocytes in active pulmonary sarcoidosis is primarily from the Leu3+DR+ T cell subset.
Saltini C; Spurzem JR; Lee JJ; Pinkston P; Crystal RG
J Clin Invest; 1986 Jun; 77(6):1962-70. PubMed ID: 3486888
[TBL] [Abstract][Full Text] [Related]
27. [Interleukin-2 (IL-2) production by activated T cells in Patients with pulmonary sarcoidosis].
Nagai S
Nihon Kyobu Shikkan Gakkai Zasshi; 1987 Sep; 25(9):977-83. PubMed ID: 3502154
[No Abstract] [Full Text] [Related]
28. Helper T-lymphocytes in pulmonary sarcoidosis. Functional analysis of a lung T-cell subpopulation in patients with active disease.
Rossi GA; Sacco O; Cosulich E; Risso A; Balbi B; Ravazzoni C
Am Rev Respir Dis; 1986 Jun; 133(6):1086-90. PubMed ID: 2940949
[TBL] [Abstract][Full Text] [Related]
29. Compartmentalized activation of the interleukin 2 gene by lung T lymphocytes in active pulmonary sarcoidosis.
Müller-Quernheim J; Saltini C; Sondermeyer P; Crystal RG
J Immunol; 1986 Dec; 137(11):3475-83. PubMed ID: 3491139
[TBL] [Abstract][Full Text] [Related]
30. In vitro release of interleukin-15 by broncho-alveolar lavage cells and peripheral blood mononuclear cells from patients with different lung diseases.
Zissel G; Bäumer I; Schlaak M; Müller-Quernheim J
Eur Cytokine Netw; 2000 Mar; 11(1):105-12. PubMed ID: 10705307
[TBL] [Abstract][Full Text] [Related]
31. The relationship between alveolar macrophage TNF, IL-1, and PGE2 release, alveolitis, and disease severity in sarcoidosis.
Pueringer RJ; Schwartz DA; Dayton CS; Gilbert SR; Hunninghake GW
Chest; 1993 Mar; 103(3):832-8. PubMed ID: 8449077
[TBL] [Abstract][Full Text] [Related]
32. Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis.
Homolka J; Müller-Quernheim J
Lung; 1993; 171(3):173-83. PubMed ID: 8505857
[TBL] [Abstract][Full Text] [Related]
33. Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis.
Moseley PL; Hemken C; Monick M; Nugent K; Hunninghake GW
Chest; 1986 May; 89(5):657-62. PubMed ID: 3084179
[TBL] [Abstract][Full Text] [Related]
34. [Alveolitis in patients with sarcoidosis].
Tomić I; Dangubić V; Popović L; Colić M; Plavec G
Vojnosanit Pregl; 1992; 49(6):547-51. PubMed ID: 1297251
[TBL] [Abstract][Full Text] [Related]
35. Clonal analysis of lung and blood T cells in patients with sarcoidosis.
Garlepp MJ; Rose AH; Dench JE; Robinson BW
Thorax; 1994 Jun; 49(6):577-85. PubMed ID: 8016795
[TBL] [Abstract][Full Text] [Related]
36. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation.
Lem VM; Lipscomb MF; Weissler JC; Nunez G; Ball EJ; Stastny P; Toews GB
J Immunol; 1985 Sep; 135(3):1766-71. PubMed ID: 3874905
[TBL] [Abstract][Full Text] [Related]
37. [Immunopathogenesis of sarcoidosis: current practical knowledge].
Müller-Quernheim J
Z Gesamte Inn Med; 1990 Oct; 45(19):573-7. PubMed ID: 2151549
[TBL] [Abstract][Full Text] [Related]
38. [Bronchoalveolar immunoglobulins in sarcoidosis].
Bauer W; Gorny MK; Morell A; Baumann HR
Schweiz Med Wochenschr; 1985 Jan; 115(3):103-5. PubMed ID: 3871964
[TBL] [Abstract][Full Text] [Related]
39. NIH conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes.
Ann Intern Med; 1981 Jan; 94(1):73-94. PubMed ID: 7004303
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of alveolar macrophages in normals and individuals with active pulmonary sarcoidosis for the spontaneous expression of the interleukin-1 beta gene.
Wewers MD; Saltini C; Sellers S; Tocci MJ; Bayne EK; Schmidt JA; Crystal RG
Cell Immunol; 1987 Jul; 107(2):479-88. PubMed ID: 3297354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
